共 60 条
[1]
Kellett. J.(1996)Cost-effectiveness of accelerated tissue plasminogen activator for acute myocardial infarction Br. J. Med. Econ. 10 341-359
[2]
Bowker T. J.(1996)A British Cardiac Society survey of potential for the secondary prevention of coronary disease ASPIRE (Action on Secondary Prevention through Intervention to Reduce events) 75 334-42
[3]
Clayton T. C.(1994)Causes of higher in-hospital mortality in women than men after acute myocardial infarction Am. J. Cardial 73 319-319
[4]
Ingham J.(1988)Marked platelet activation Circulation 77 142-150
[5]
McLennan N. R.(1994) after intravenous streptokinase in patients with acute myocardial infarction Blood 8 680-686
[6]
Hobson H. L.(1991)Staphylokinase, a fibrin-specific plasminogen activator with therapeutic potential Cathet. Cardiavasc. Diagn. 24 75-75
[7]
Pyke S. D.(1988)Cardiac Catheterization 1990: A report of the Society for Cardiac Angiography and Interventions Arch. Surg. 123 1207-1207
[8]
Schofield B.(1996)Vascular complications of percutaneous femoral cardiac interventions J. Am. Coll. Cardiol. 27 1185-91
[9]
Wood D. A.(1993)Three year follow up after Palmaz-Schatz stenting Am. Heart J. 126 1049-58
[10]
Jenkins J. S.(1983)Effects of stent design and serum cholesterol level on the restenosis rate in atherosclerotic rabbits Metabolism 32 943-9